Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

The genetic testing firm will also close its drug development arm. CEO Anne Wojcicki said the cuts are necessary to “focus on ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...